Adicet Bio Inc (ACET)
1.45
+0.04
(+2.84%)
USD |
NASDAQ |
May 03, 16:00
1.455
0.00 (0.00%)
After-Hours: 20:00
Adicet Bio Cash from Financing (Quarterly): 0.076M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.076M |
| September 30, 2023 | -0.059M |
| June 30, 2023 | 0.226M |
| March 31, 2023 | -0.007M |
| December 31, 2022 | 0.304M |
| September 30, 2022 | 42.18M |
| June 30, 2022 | 0.163M |
| March 31, 2022 | -1.134M |
| Date | Value |
|---|---|
| December 31, 2021 | 97.46M |
| September 30, 2021 | 0.362M |
| June 30, 2021 | -0.027M |
| March 31, 2021 | 144.89M |
| December 31, 2020 | 0.267M |
| September 30, 2020 | 0.144M |
| June 30, 2020 | -0.15M |
| March 31, 2020 | 0.042M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.134M
Minimum
Mar 2022
144.89M
Maximum
Mar 2021
17.80M
Average
0.1535M
Median
Cash from Financing (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | -0.665M |
| Codexis Inc | 0.00 |
| Annexon Inc | 117.60M |
| Taysha Gene Therapies Inc | -4.248M |
| Praxis Precision Medicines Inc | 4.126M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -23.49M |
| Cash from Investing (Quarterly) | -0.136M |
| Free Cash Flow | -98.18M |
| Free Cash Flow Per Share (Quarterly) | -0.5473 |
| Free Cash Flow Yield | -157.4% |